Corebridge gets Nippon Life buy under a preset plan

What happened

Corebridge Financial, Inc. (NYSE: CRBG) filed a Form 4 showing Nippon Life Insurance Co., a 10% owner, bought 258,878 shares of common stock on 2026-09-24. The weighted-average price was $33.8532 a share. The filing says the trade followed a Rule 10b5-1 trading plan adopted on August 7, 2026.

The shares were bought in multiple transactions at prices from $33.55 to $34.14. After the purchase, Nippon Life Insurance Co. reported 124,595,032 shares, including 124,561,761 shares held of record and 33,271 shares held of record by Nissay Asset Management Corporation, a direct wholly owned subsidiary. Yohei Miyanaga, General Manager, signed the filing on 09/28/2026.

Key numbers

Metric Latest Change Source
Shares bought 258,878 shares SEC Form 4
Weighted-average price $33.8532 per share SEC Form 4
Total purchase value about $8.76 million SEC Form 4
Post-trade holding 124,595,032 shares SEC Form 4
Buy as share of pre-trade holding 0.2% Calculated from SEC Form 4

Why it matters

OptimistFi's case is that Corebridge works if its retirement and life-insurance balance sheet keeps producing distributable spread cash. The case also says 2025's GAAP loss looks like accounting or market-cycle noise, not a break in underwriting, hedging, or capital strength. This filing adds a fresh ownership datapoint, but it does not test those operating claims.

The buy was about 0.2% of the holding before the trade. That is the 258,878-share purchase compared with the pre-trade position implied by the filing. It adds to the stake, but it does not change the larger ownership picture.

The post-trade position was 124,595,032 shares. That includes 124,561,761 shares held of record and 33,271 held by Nissay Asset Management Corporation. The weighted-average price and the $33.55 to $34.14 range show several fills, not a single print.

The main caveat is that a Rule 10b5-1 plan can mean the trade followed a preset schedule rather than a fresh view. So the Form 4 helps size the stake, but it is weak evidence of new conviction.

What's next

The next test is Corebridge Financial, Inc.'s next quarterly report. That filing will matter because it can show whether the business still matches the thesis on cash generation, underwriting, hedging, and capital strength.

If those points hold up, the buy will sit beside the thesis as another ownership datapoint. If they slip, this Form 4 will look more like background noise from a scheduled plan than an active view.

Sources

  • SEC Form 4 — Corebridge Financial, Inc. insider filing dated 2026-09-28

Read the full OptimistFi thesis on Corebridge Financial, Inc.: https://optimistfi.com/stocks/CRBG

See what would break the Corebridge Financial, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.

Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.

The full Corebridge Financial, Inc. investment case, its status and the next test to watch live on the Corebridge Financial, Inc. thesis page.

Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.